Change to chemo compounding claims | AJP

Change to chemo compounding claims | AJP: The Government has advised on changes for compounding pharmacists and other suppliers From 1 December 2017, approved suppliers (approved pharmacists, approved medical practitioners and approved ...

11/14/2017

Mannatech Incorporated

Dallas District Office

CGMP/Manufacturing, Packaging, Labeling, or Holding Operations for Dietary Supplements/Adulterated

Not Issued *

11/09/2017

TSDR Pharmacy Inc. dba brandMD Skin Care

Los Angeles District Office

Compounding Pharmacy/Adulterated Drug Products

Not Issued *

11/08/2017

Vita Pure Inc

Baltimore District Office

CGMP/Manufacturing, Packaging, Labeling, or Holding Operations for Dietary Supplements/Adulterated

Not Issued *

11/06/2017

Hubei Danao Pharmaceutical Co., Ltd.

Center for Drug Evaluation and Research

CGMP/Active Pharmaceutical Ingredient (API)/Adulterated

Not Issued *

10/27/2017

RAM Pharma, Inc

Los Angeles District Office

Compounding Pharmacy/Adulterated Drug Products

Not Issued *

09/18/2017

Strohecker's Pharmacy

Los Angeles District Office

Compounding Pharmacy/Adulterated Drug Products

Not Issued

Self: These Weight-Loss and Workout Supplements Contain Banned Ingredients Under Sneaky Names

https://www.msn.com/en-us/health/healthtrending/these-weight-loss-and-workout-supplements-contain-banned-ingredients-under-sneaky-names/ar-BBFsnSg?li=BBmkt5R&ocid=spartandhp

FDA Statement Statement from FDA Commissioner Scott Gottlieb, M.D., on steps to promote development of generic versions of opioids formulated to deter abuse

	As we continue to confront the staggering human and economic toll created by opioid abuse and addiction, we’re focused on taking actions that reduce the scope of new addiction by decreasing unnecessary exposure to opioids. At the same time, we also must take steps to help those with acute and chronic pain who need access to medicines, including opioids, get access to improved alternatives. Until we’re able to find new non-opioid forms of pain management for those who need treatment for pain, it’s critical that we also continue to promote the development of opioids that are harder to manipulate and abuse, and take steps to encourage their use over opioids that don’t offer any form of abuse deterrence. Continue reading.

PCAC Votes Against FDA, Recommendation in a 6 - 5 Vote to ADD Pregnenolone to the API Positive List - International Academy of Compounding Pharmacists

PCAC Votes Against FDA, Recommendation in a 6 - 5 Vote to ADD Pregnenolone to the API Positive List - International Academy of Compounding Pharmacists